Nature CommunicationsPhysiologyPeer-reviewed journal article
Dietary protein governs the role of insulin signaling in the postprandial regulation of hepatic mTORC1
Krystle C. KalafutiD, Yann CormeraisiD, Madi Y. CisséiD, Samuel C. Lapp, Karen InouyeiD, Gökhan S. HotamışlıgiliD, Brendan D. ManningiD
Abstract
The nutrient-sensing mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway controls cellular and organismal growth and metabolism, while aberrant activation is linked to human disease, including metabolic disease. Cellular studies have established several regulatory mechanisms influencing mTORC1 activation, but the physiological signals that control mTORC1 at the organismal and tissue levels are less well defined. mTORC1 is dynamically regulated by fasting and feeding in metabolic tissues, with both nutrients and insulin proposed to activate mTORC1 in response to feeding. Here, a liver-specific mouse model that disconnects mTORC1 activation from AKT-mediated TSC2 phosphorylation is employed. This genetic mouse model demonstrates that AKT-mediated TSC2 phosphorylation is the predominant mechanism of hepatic mTORC1 induction by insulin but is dispensable for activation by feeding. Furthermore, dietary protein is critical and dictates the insulin-responsiveness of hepatic mTORC1 signaling. Contrary to dogma, hepatic mTORC1 signaling was not elevated in response to diet-induced obesity associated with the phenotypes of type-2 diabetes, including hyperinsulinemia, systemic insulin resistance, and hyperglycemia, and blocking hepatic AKT-TSC-mTORC1 signaling did not prevent these metabolic impairments. Evidence is also provided supporting a role for glucagon in hepatic mTORC1 suppression during fasting. This study reveals a hierarchy of physiological signals regulating hepatic mTORC1.
- organism: mouse
- research focus: cell type annotation
- research focus: chromatin & epigenetic regulation
- research focus: metabolism & bioenergetics
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 1
- FWCI
- 2.07
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin
V. Byles, Y. Cormerais, … B. D. Manning·bioRxiv·May 2, 2021
- Manganese availability determines insulin sensitivity by enhancing Akt activity
Jennifer R. Gamarra, Sei Higuchi, … Rebecca A. Haeusler·bioRxiv·Sep 17, 2026
- Diet induced insulin resistance is due to induction of PTEN expression
Radha Mukherjee, Priya Pancholi, … Neal X. Rosen·bioRxiv·Mar 25, 2025
- Selective phosphorylation of AKT isoforms in response to dietary cues
L. C. Trautenberg, E. Prince, … M. Brankatschk·bioRxiv·Jul 5, 2019
- Suppression of ITPK1 and IPMK activities impairs mTORC1 signaling due to accelerated signal termination and prevents pancreatic β-cell metabolic adaptation to excess glucose
Clarisse Iradukunda, E. Alan Salter, … Lucia E. Rameh·bioRxiv·Mar 7, 2026
- Transcriptomic analysis of human and mouse muscle during hyperinsulinemia demonstrates insulin receptor downregulation as a mechanism for insulin resistance
H. H. Cen, J. D. Botezelli, … J. A. Timmons·bioRxiv·Mar 21, 2021